ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027

ATPアッセイの世界市場予測(~2027):製品別、用途別、エンドユーザー別

◆タイトル:ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
◆商品コード:AST7417-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年4月7日
◆ページ数:222
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のATPアッセイ市場規模が2022年276百万ドルから2027年412百万ドルまで、年平均8.4%成長すると予想しています。本市場調査資料では、ATPアッセイの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品・付属品、機器)分析、用途別(汚染検査、疾病検査、創薬・開発)分析、エンドユーザー別(製薬・バイオテクノロジー企業、食品・飲料産業、病院・診断研究機関、学術・研究機関)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のATPアッセイ市場規模:製品別(消耗品・付属品、機器)
・世界のATPアッセイ市場規模:用途別(汚染検査、疾病検査、創薬・開発)
・世界のATPアッセイ市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、食品・飲料産業、病院・診断研究機関、学術・研究機関)
・世界のATPアッセイ市場規模:地域別
・競争状況
・企業情報

“The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%.”
The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests. However, the high cost of instruments and inability to differentiate between extracellular and intracellular ATP are expected to restrain the growth of this market to a certain extent.

“The consumables and accessories segment accounted for the largest share of the ATP assays, based on product in 2021.”
Based on products, the ATP assays market is segmented into consumables & accessories and instruments. The large share of consumables & accessories segment is attributed to the extensive usage of ATP assays in research institutes to measure cell viability, increase in drug discovery due to a surge in chronic diseases which requires tumor testing and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.

“Contamination Testing accounted for the largest share of the market.”
The ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. The large share of the contamination testing segment can be attributed to the rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals.

“Pharmaceutical & Biotechnology companies hold the largest share in the market, by end user.”
The large share of Pharmaceutical & Biotechnology companies in the end user segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.

“The APAC to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. This regional market is expected to register the highest growth rate during the forecast period as several APAC countries are witnessing a growing number of proteomics, genomics, and stem cell research activities. The increasing incidence of chronic & infectious diseases, increasing drug discovery & development studies, favorable regulatory guidelines, the growing focus of global market players on emerging Asian economies, increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and research infrastructure modernization are some of the key factors driving the market for ATP assays.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the ATP Assays Market:
The prominent players in the ATP assays market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), NEOGEN Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech LLC (US), Cayman Chemical (US), and Cell Signaling Technology (US).

Research Coverage:
The report analyzes the ATP assays market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a product portfolio matrix of various ATP assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the ATP assays market. The report analyzes this market by product, by application, and by end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global ATP assays market.
• Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ATP assays market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global ATP assays market.

【レポートの目次】

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION & SCOPE 24
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 25
1.2.2 MARKET SEGMENTATION 25
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION 25
1.2.3 YEARS CONSIDERED FOR THE STUDY 26
1.3 CURRENCY 26
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 26
1.4 STAKEHOLDERS 27
1.5 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 34
2.2 MARKET SIZE ESTIMATION 34
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 35
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 35
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37
FIGURE 10 CAGR PROJECTIONS 37
FIGURE 11 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 39
FIGURE 12 DATA TRIANGULATION METHODOLOGY 39
2.4 MARKET RANKING ANALYSIS 40
2.5 ASSUMPTIONS FOR THE STUDY 40
2.6 LIMITATIONS 40
2.6.1 METHODOLOGY-RELATED LIMITATIONS 40
2.6.2 SCOPE-RELATED LIMITATIONS 41
2.7 RISK ASSESSMENT 41
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 13 ATP ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 42
FIGURE 14 ATP ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 43
FIGURE 15 ATP ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 43
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE ATP ASSAYS MARKET 44
4 PREMIUM INSIGHTS 46
4.1 ATP ASSAYS MARKET OVERVIEW 46
FIGURE 17 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET GROWTH 46
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2021) 47
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2021 47
4.3 ATP ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH IN THE ATP ASSAYS MARKET DURING THE FORECAST PERIOD 48
4.4 ATP ASSAYS MARKET, BY REGION (2020–2027) 49
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ATP ASSAYS MARKET IN 2027 49
4.5 ATP ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS 49
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
TABLE 3 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 MARKET DRIVERS 51
5.2.1.1 Increasing food safety concerns 51
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies 52
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D 52
FIGURE 22 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 (USD BILLION) 53
5.2.1.4 Increasing prevalence of cancer 53
FIGURE 23 GLOBAL CANCER INCIDENCE, 2018 VS. 2030 (MILLION) 54
5.2.1.5 Shift from culture-based tests to rapid-tests 54
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases 55
5.2.2 MARKET RESTRAINTS 56
5.2.2.1 High cost of instruments 56
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP 56
5.2.3 MARKET OPPORTUNITIES 57
5.2.3.1 Technological enhancements in ATP assay probes 57
5.2.3.2 Growth prospects in emerging markets 57
5.2.4 MARKET CHALLENGES 58
5.2.4.1 Survival of small players and new entrants 58
5.3 INDUSTRY TRENDS 58
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES 58
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2 59
5.4 IMPACT OF COVID-19 ON THE ATP ASSAYS MARKET 59
5.5 PATENT ANALYSIS 60
5.5.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS 60
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–FEBRUARY 2022) 61
5.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 61
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–FEBRUARY 2022) 62
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ATP ASSAYS
(JANUARY 2011–FEBRUARY 2022) 63
5.5.3 LIST OF PATENTS/PATENT APPLICATIONS IN THE ATP ASSAYS MARKET 63
5.6 VALUE CHAIN ANALYSIS 65
FIGURE 27 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS 65
5.7 ECOSYSTEM ANALYSIS 66
FIGURE 28 ATP ASSAYS MARKET: ECOSYSTEM ANALYSIS 66
5.8 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 4 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.8.1 THREAT OF NEW ENTRANTS 67
5.8.2 THREAT OF SUBSTITUTES 67
5.8.3 BARGAINING POWER OF SUPPLIERS 67
5.8.4 BARGAINING POWER OF BUYERS 68
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.9 PRICING ANALYSIS 68
5.9.1 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD) 69
6 ATP ASSAYS MARKET, BY PRODUCT 70
6.1 INTRODUCTION 71
TABLE 5 ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 71
6.2 CONSUMABLES & ACCESSORIES 71
TABLE 6 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE IN THE MARKET 72
TABLE 7 ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 72
TABLE 8 ATP CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 73
6.2.1 REAGENTS & KITS 73
6.2.1.1 Reagents play a significant role in the identification and detection of cells in cancer research 73
TABLE 9 REAGENTS & KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.2.2 MICROPLATES 75
6.2.2.1 Extensive use of microplates for assay development is driving their adoption 75
TABLE 10 MICROPLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.3 OTHER CONSUMABLES & ACCESSORIES 76
TABLE 11 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 77
6.3 INSTRUMENTS 77
TABLE 12 ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
TABLE 13 ATP INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
TABLE 14 KEY ATP INSTRUMENTS AVAILABLE IN THE MARKET 78
6.3.1 LUMINOMETERS 79
6.3.1.1 Luminometers are comparatively low-priced and, therefore, widely adopted 79
TABLE 15 LUMINOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3.2 SPECTROPHOTOMETERS 80
6.3.2.1 Spectrophotometers are costlier than luminometers and, therefore, less preferred by end users in the ATP assays market 80
TABLE 16 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
7 ATP ASSAYS MARKET, BY APPLICATION 81
7.1 INTRODUCTION 82
TABLE 17 ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82
7.2 CONTAMINATION TESTING 82
7.2.1 NEED TO MEET REGULATORY MANDATES FOR CONTAMINATION AND QUALITY TESTING IS A KEY FACTOR DRIVING MARKET GROWTH 82
TABLE 18 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY,
2020–2027 (USD MILLION) 83
7.3 DISEASE TESTING 83
7.3.1 GROWING DISEASE INCIDENCE AND RISING AWARENESS ARE EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD 83
TABLE 19 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY,
2020–2027 (USD MILLION) 85
7.4 DRUG DISCOVERY & DEVELOPMENT 85
7.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS WILL DRIVE MARKET GROWTH 85
TABLE 20 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 86
8 ATP ASSAYS MARKET, BY END USER 87
8.1 INTRODUCTION 88
TABLE 21 ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 88
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 88
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF ATP ASSAYS 88
TABLE 22 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 89
8.3 FOOD & BEVERAGE INDUSTRY 90
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION TO DRIVE THE ADOPTION OF ATP ASSAYS 90
TABLE 23 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 91
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 91
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS IS A MAJOR FACTOR DRIVING THE ADOPTION OF ATP ASSAYS 91
TABLE 24 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2020–2027 (USD MILLION) 92
8.5 ACADEMIC & RESEARCH INSTITUTES 93
8.5.1 ATP ASSAYS ARE USED FOR RESEARCH ACTIVITIES RELATED TO THE GROWTH RATE & VIABILITY OF MICROORGANISMS 93
TABLE 25 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 93
9 ATP ASSAYS MARKET, BY REGION 94
9.1 INTRODUCTION 95
TABLE 26 ATP ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
9.2 NORTH AMERICA 96
FIGURE 30 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT 97
TABLE 27 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 98
TABLE 28 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 98
TABLE 29 NORTH AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 30 NORTH AMERICA: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 99
TABLE 31 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 99
TABLE 32 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION) 99
9.2.1 US 100
9.2.1.1 US dominates the North American ATP assays market 100
TABLE 33 US: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
TABLE 34 US: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 101
TABLE 35 US: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 36 US: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
TABLE 37 US: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 102
9.2.2 CANADA 102
9.2.2.1 Government funding programs for life science research to drive market growth 102
TABLE 38 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103
TABLE 39 CANADA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
TABLE 40 CANADA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 41 CANADA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 104
TABLE 42 CANADA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.3 EUROPE 104
FIGURE 31 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, 2000–2018 (USD BILLION) 105
TABLE 43 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 44 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106
TABLE 45 EUROPE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 106
TABLE 46 EUROPE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 47 EUROPE: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 107
TABLE 48 EUROPE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.3.1 GERMANY 108
9.3.1.1 Demand for ATP assays is driven by the large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers 108
TABLE 49 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 50 GERMANY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 51 GERMANY: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 52 GERMANY: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 110
TABLE 53 GERMANY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.3.2 UK 110
9.3.2.1 UK has the largest pharmaceutical R&D expenditure in Europe 110
TABLE 54 UK: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 55 UK: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 111
TABLE 56 UK: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 57 UK: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112
TABLE 58 UK: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 112
9.3.3 FRANCE 113
9.3.3.1 Strong agro-food sector and a major focus on biotechnology
R&D to drive market growth in France 113
TABLE 59 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 60 FRANCE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
TABLE 61 FRANCE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 62 FRANCE: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 114
TABLE 63 FRANCE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 115
9.3.4 ITALY 115
9.3.4.1 High cancer burden to increase the demand for ATP assays in Italy 115
TABLE 64 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116
TABLE 65 ITALY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 66 ITALY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 67 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 68 ITALY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.3.5 SPAIN 117
9.3.5.1 Growth in the personalized medicine sector and clinical diagnostics market to drive the ATP assays market in Spain 117
TABLE 69 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 118
TABLE 70 SPAIN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 118
TABLE 71 SPAIN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 72 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 73 SPAIN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.3.6 REST OF EUROPE 120
TABLE 74 ROE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 75 ROE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 121
TABLE 76 ROE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 77 ROE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 78 ROE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
9.4 ASIA PACIFIC 122
FIGURE 32 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT 123
TABLE 79 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 124
TABLE 80 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 124
TABLE 81 ASIA PACIFIC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 82 ASIA PACIFIC: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 125
TABLE 83 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 125
TABLE 84 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION) 125
9.4.1 CHINA 126
9.4.1.1 Increasing pharmaceutical R&D investments in the country to support market growth 126
TABLE 85 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 126
TABLE 86 CHINA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 87 CHINA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 88 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 127
TABLE 89 CHINA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 128
9.4.2 JAPAN 128
9.4.2.1 High incidence of cancer to increase the demand for
ATP assays in Japan 128
TABLE 90 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 91 JAPAN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 129
TABLE 92 JAPAN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 93 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 94 JAPAN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 130
9.4.3 INDIA 131
9.4.3.1 Growing adoption of ATP assay techniques in research and clinical applications to drive the market in India 131
TABLE 95 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 96 INDIA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 132
TABLE 97 INDIA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 98 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 99 INDIA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
9.4.4 REST OF APAC 133
TABLE 100 ROAPAC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 101 ROAPAC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 102 ROAPAC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 103 ROAPAC: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 104 ROAPAC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
9.5 LATIN AMERICA 135
TABLE 105 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 136
TABLE 106 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 136
TABLE 107 LATIN AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 108 LATIN AMERICA: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 137
TABLE 109 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 137
TABLE 110 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION) 138
9.5.1 BRAZIL 138
9.5.1.1 Increasing research activities & expanding pharmaceutical market in Brazil is fueling the market for ATP assays 138
TABLE 111 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
TABLE 112 BRAZIL: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 113 BRAZIL: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 114 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 115 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 140
9.5.2 MEXICO 140
9.5.2.1 Increase in research centers and manufacturing to drive the demand for ATP assays in Mexico 140
TABLE 116 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 117 MEXICO: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 118 MEXICO: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 119 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 120 MEXICO: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 142
9.5.3 REST OF LATIN AMERICA 143
TABLE 121 ROLATAM: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
TABLE 122 ROLATAM: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 143
TABLE 123 ROLATAM: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 124 ROLATAM: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 144
TABLE 125 ROLATAM: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 144
9.6 MIDDLE EAST & AFRICA 145
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IS DRIVING MARKET GROWTH IN THE MEA 145
TABLE 126 MEA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 127 MEA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION) 146
TABLE 128 MEA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 129 MEA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 130 MEA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 147
10 COMPETITIVE LANDSCAPE 148
10.1 OVERVIEW 148
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 148
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN
THE ATP ASSAYS MARKET 149
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 151
FIGURE 33 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE ATP ASSAYS MARKET 151
10.4 MARKET RANKING ANALYSIS 151
FIGURE 34 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2021 152
10.5 COMPETITIVE LEADERSHIP MAPPING 153
10.5.1 STARS 153
10.5.2 EMERGING LEADERS 153
10.5.3 PERVASIVE PLAYERS 153
10.5.4 PARTICIPANTS 153
FIGURE 35 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 154
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS 154
10.6.1 PROGRESSIVE COMPANIES 154
10.6.2 DYNAMIC COMPANIES 155
10.6.3 STARTING BLOCKS 155
10.6.4 RESPONSIVE COMPANIES 155
FIGURE 36 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR STARTUPS (2021) 155
10.7 COMPANY FOOTPRINT 156
TABLE 131 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2021) 156
10.7.1 PRODUCT FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET 157
TABLE 132 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2021) 157
10.7.2 APPLICATION FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET 158
TABLE 133 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2021) 158
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET 159
TABLE 134 END-USER FOOTPRINT: ATP ASSAYS MARKET (2021) 159
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET 160
TABLE 135 GEOGRAPHIC FOOTPRINT: ATP ASSAYS MARKET (2021) 160
10.8 COMPETITIVE SCENARIO 161
10.8.1 PRODUCT LAUNCHES 161
TABLE 136 PRODUCT LAUNCHES, JANUARY 2018–FEBRUARY 2022 161
10.8.2 DEALS 162
TABLE 137 DEALS, JANUARY 2018–FEBRUARY 2022 162
10.8.3 OTHER DEVELOPMENTS 164
11 COMPANY PROFILES 165
11.1 KEY PLAYERS 165
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 165
TABLE 139 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 165
FIGURE 37 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 166
11.1.2 PROMEGA CORPORATION 170
TABLE 140 PROMEGA CORPORATION: BUSINESS OVERVIEW 170
11.1.3 MERCK KGAA 173
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021) 174
11.1.4 NEOGEN CORPORATION 177
TABLE 142 NEOGEN CORPORATION: BUSINESS OVERVIEW 177
FIGURE 39 NEOGEN CORPORATION: COMPANY SNAPSHOT (2021) 178
11.1.5 PERKINELMER, INC. 181
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 182
11.1.6 AGILENT TECHNOLOGIES, INC. 185
FIGURE 41 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021) 186
11.1.7 PROMOCELL GMBH 189
11.1.8 DANAHER CORPORATION 190
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 191
11.1.9 LONZA GROUP 193
TABLE 147 LONZA GROUP: BUSINESS OVERVIEW 193
FIGURE 43 LONZA GROUP: COMPANY SNAPSHOT (2021) 194
11.1.10 ABCAM PLC 196
FIGURE 44 ABCAM PLC: COMPANY SNAPSHOT (2021) 197
11.1.11 3M 199
FIGURE 45 3M: COMPANY SNAPSHOT (2021) 200
11.1.12 ABNOVA CORPORATION 201
FIGURE 46 ABNOVA CORPORATION: COMPANY SNAPSHOT (2020) 201
11.1.13 GENO TECHNOLOGY, INC. 203
TABLE 151 GENO TECHNOLOGY, INC.: BUSINESS OVERVIEW 203
11.1.14 AAT BIOQUEST, INC. 205
TABLE 152 AAT BIOQUEST, INC.: BUSINESS OVERVIEW 205
11.1.15 BIOTHEMA AB 207
11.1.16 BIOTIUM 209
11.1.17 CREATIVE BIOARRAY 210
11.1.18 CANVAX BIOTECH S.L. 211
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC. 212
11.1.20 MBL INTERNATIONAL CORPORATION 213
TABLE 158 MBL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW 213
11.2 OTHER COMPANIES 214
11.2.1 RUHOF CORPORATION 214
11.2.2 CHARM SCIENCES 215
11.2.3 BIO SHIELD TECH, LLC 216
11.2.4 CAYMAN CHEMICAL 217
11.2.5 CELL SIGNALING TECHNOLOGY 217
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 218
12.1 INSIGHTS FROM INDUSTRY EXPERTS 218
12.2 DISCUSSION GUIDE 219
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 223
12.4 AVAILABLE CUSTOMIZATIONS 225
12.5 RELATED REPORTS 225
12.6 AUTHOR DETAILS 226



★調査レポート[ATPアッセイの世界市場予測(~2027):製品別、用途別、エンドユーザー別] ( ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027 / AST7417-22) 販売に関する免責事項
[ATPアッセイの世界市場予測(~2027):製品別、用途別、エンドユーザー別] ( ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027 / AST7417-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆